Chiara Baggio

Via Giustiniani, 2
Padova, 35128, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 28 publications

Inflammatory blood count ratios discriminate disease activity and remain persistently elevated during glucocorticoid-free remission in ANCA-associated vasculitis.

Inflammatory blood count ratios discriminate disease activity and remain persistently elevated during glucocorticoid-free remission in ANCA-associated vasculitis.

Journal: Clinical and experimental medicine

Published: March 17, 2026

Gout: one year in review 2026.

Gout: one year in review 2026.

Journal: Clinical and experimental rheumatology

Published: February 11, 2026

Immature leukocyte and plasma-induced cell death reveal subclinical immune activation in EGPA patients in remission.

Immature leukocyte and plasma-induced cell death reveal subclinical immune activation in EGPA patients in remission.

Journal: Inflammation research : official journal of the European Histamine Research Society ... [et al.]

Published: September 01, 2025

Clinical and laboratory markers to distinguish VEXAS from Schnitzler's syndrome: data from the AIDA network registries.

Clinical and laboratory markers to distinguish VEXAS from Schnitzler's syndrome: data from the AIDA network registries.

Journal: Frontiers in medicine

Published: August 01, 2025

Hydrogen Peroxide Modulates the Timely Activation of Jun and Erk in Schwann Cells at the Injury Site and Is Required for Motor Axon Regeneration.

Hydrogen Peroxide Modulates the Timely Activation of Jun and Erk in Schwann Cells at the Injury Site and Is Required for Motor Axon Regeneration.

Journal: Cells

Published: March 26, 2025

Gout: one year in review 2025.

Gout: one year in review 2025.

Journal: Clinical and experimental rheumatology

Published: February 19, 2025

Unresolved Issues in Familial Mediterranean Fever: Is p.R202Q MEFV Variant Potentially Pathogenetic in Unleashing Inflammation?

Unresolved Issues in Familial Mediterranean Fever: Is p.R202Q MEFV Variant Potentially Pathogenetic in Unleashing Inflammation?

Journal: Journal of clinical immunology

Published: January 15, 2025

Multitargeted biological actions of polydatin in preventing pseudogout acute attack.

Multitargeted biological actions of polydatin in preventing pseudogout acute attack.

Journal: Frontiers in molecular biosciences

Published: December 31, 2024

Efficacy and safety of conventional disease-modifying antirheumatic drugs in VEXAS syndrome: real-world data from the international AIDA network.

Efficacy and safety of conventional disease-modifying antirheumatic drugs in VEXAS syndrome: real-world data from the international AIDA network.

Journal: Frontiers in pharmacology

Published: December 04, 2024

Expanding the VEXAS diagnostic workup: the role of peripheral blood cytological analysis.

Expanding the VEXAS diagnostic workup: the role of peripheral blood cytological analysis.

Journal: Frontiers in immunology

Published: July 18, 2024

Efficacy and safety profile of biotechnological agents and Janus kinase inhibitors in VEXAS syndrome: data from the international AIDA Network VEXAS registry.

Efficacy and safety profile of biotechnological agents and Janus kinase inhibitors in VEXAS syndrome: data from the international AIDA Network VEXAS registry.

Journal: Frontiers in pharmacology

Published: July 09, 2024

Proteomic Profiling of Tears in Blau Syndrome Patients in Identification of Potential Disease Biomarkers.

Proteomic Profiling of Tears in Blau Syndrome Patients in Identification of Potential Disease Biomarkers.

Journal: International journal of molecular sciences

Published: May 20, 2024

Showing 1-12 of 28

Last Updated: 09/26/2026